Advanced Search

 

Study ID Status Title Patient Level Data
114089 Completed A Phase I, Randomized, Placebo-Controlled, Crossover Clinical Trial to Assess the Safety of Oral SRT2104 and its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114092 Completed A multicenter, open-label, dose ranging study to determine the pharmacokinetics and pharmacodynamics of mepolizumab administered intravenously or subcutaneously to adult asthmatic subjects with elevated blood eosinophil levels Study Listed on ClinicalStudyDataRequest.com
114101 Completed Post-marketing safety study to assess the risk of spontaneous abortions in women exposed to Cervarix in the United Kingdom
114102 Completed Special Drug Use Investigation for PAXIL (paroxetine) Social Anxiety Disorder (Long-term)
114107 Completed An open label, randomised healthy volunteer study to assess the single dose safety and pharmacokinetics of three modified release dosage forms of firategrast
114111 Completed A Randomized, Double-Blind, Active- and Placebo-Controlled, Crossover Study Assessing the Effect of 600 mg Gabapentin Enacarbil on Simulated Driving in Healthy Subjects
114112 Completed A Randomized, Double-blind, Single Dose Crossover Study to Assess the Effect of Gabapentin Enacarbil on Cardiac Conduction as Compared with Placebo and Moxifloxacin in Healthy Volunteers
114117 Completed A phase II, double blind, exploratory, parallel-group, placebocontrolled clinical study to assess two dosing regimens of GSK2402968 for efficacy, safety, tolerability and pharmacokinetics in ambulant subjects with Duchenne muscular dystrophy
114118 Completed A double-blind, escalating dose, randomized, placebo-controlled study to assess the pharmacokinetics, safety and tolerability of single subcutaneous injections of GSK2402968 in non-ambulant subjects with Duchenne muscular dystrophy
114125 Completed Drug Use Investigation for AVOLVE(BPH)
114128 Completed Drug Use Investigation for Arepanrix® (H1N1)
114130 Completed A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment Study Listed on ClinicalStudyDataRequest.com
114136 Completed A single dose, open label, nonrandomized, study to evaluate the pharmacokinetics and absolute bioavailability of GSK962040 given as an oral dose simultaneously with an intravenous microtracer dose of [14C]-GSK962040 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114137 Completed An open label, randomized, up-titration study to assess the effect of urine sample handling procedures on the safety results of urine obtained from healthy subjects receiving repeat doses of ezogabine/retigabine. Study Listed on ClinicalStudyDataRequest.com
114151 Completed A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease
114155 Completed An open-label pilot study to evaluate the safety, tolerability,pharmacokinetics, exploratory efficacy and pharmacodynamicsof oral pazopanib administered for 28 days to neovascular age-relatedmacular degeneration patients
114156 Completed A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Japanese Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
114157 Terminated A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn’s Disease
114161 Completed A Six-Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Indian Postmenopausal Women with Osteoporosis
114163 Completed A Six Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study with a Six Month Open-Label Extension to Evaluate the Efficacy and Safety of Denosumab in Korean Postmenopausal Women with Osteoporosis
114165 Completed A Twelve-Month Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Chinese Postmenopausal Women with Osteoporosis at Increased Risk of Fracture
114169 Completed A 24 Week Study to Evaluate the Predictive Ability of the COPD Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
114174 Completed Impact of GSK Biologicals’ 2189242A vaccine on nasopharyngeal carriage, safety and immunogenicity when co-administered with routine EPI vaccines in infants following safety assessment in children aged 2-4 years in The Gambia Study Listed on ClinicalStudyDataRequest.com
114176 Terminated Post-marketing safety study to assess the risk of spontaneous abortion following administration of CERVARIX in the United States and Canada
114179 Completed A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.